Amol Akhade/LinkedIn
Jan 24, 2025, 14:12
Amol Akhade: Do we need phase 3 clinical trials for oncology drug approvals?
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on LinkedIn about his recent editorial published in Indian Journal of Cancer:
“My Editorial published in Indian Journal of Cancer.
Do we need Phase 3 Clinical trials for oncology drug approvals?
Do read and comment.
Last line is my favorite.
Remember, just like for life in general, barring few exceptions, there are no shortcuts to any place worth going.”
“Do we need phase 3 randomized clinical trials for oncology drug approvals?”
Author: Amol Akhade
More posts featuring Amol Akhade.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 11, 2025, 18:14
May 11, 2025, 18:05
May 11, 2025, 17:07
May 11, 2025, 16:57
May 11, 2025, 16:49